Industry Statistics
- Companies: 14
- Median P/E: 30.4 (vs. sector 26.6)
- Average ROE: 9.4% (vs. sector 7.0%)
- Average debt/equity: 0.86 (vs. sector 0.80)
- Average dividend yield: 0.9% (vs. sector 0.5%)
- Average net margin: 6.3% (vs. sector -0.2%)
- Total market cap: $242.3B
Cheapest by P/E
- Zoetis Inc. (ZTS) — P/E 11.5
- Indivior Pharmaceuticals Inc (INDV) — P/E 12.6
- Haleon plc (HLN) — P/E 18.1
- Lantheus Holdings, Inc. (LNTH) — P/E 23.8
- Dr. Reddy's Laboratories Limited (RDY) — P/E 30.4
Top Dividend Payers
- Takeda Pharmaceutical Company Limited (TAK) — 3.6%
- Zoetis Inc. (ZTS) — 3.0%
- Viatris Inc. (VTRS) — 2.7%
- Haleon plc (HLN) — 2.2%
- Dr. Reddy's Laboratories Limited (RDY) — 0.7%
Top Companies by Market Cap
- Takeda Pharmaceutical Company Limited (TAK) — $58.9B · P/E 49.4
- Teva Pharmaceutical Industries Limited (TEVA) — $46.2B · P/E 62.4
- Haleon plc (HLN) — $38.8B · P/E 18.1
- Zoetis Inc. (ZTS) — $29.2B · P/E 11.5
- Viatris Inc. (VTRS) — $20.5B
- Elanco Animal Health Incorporated (ELAN) — $11.2B
- Dr. Reddy's Laboratories Limited (RDY) — $10.2B · P/E 30.4
- Alkermes plc (ALKS) — $6.7B · P/E 106.1
- Lantheus Holdings, Inc. (LNTH) — $6.5B · P/E 23.8
- Indivior Pharmaceuticals Inc (INDV) — $4.5B · P/E 12.6
- Curaleaf Holdings, Inc. (CURA.TO) — $2.5B
- Supernus Pharmaceuticals, Inc. (SUPN) — $2.5B
- HUTCHMED (China) Limited (HCM) — $2.5B · P/E 155.0
- Bausch Health Companies Inc. (BHC) — $2.2B
Related industries
- Drug Manufacturers - General · 16 · $4.12T
- Biotechnology · 98 · $1.07T
- Medical - Diagnostics & Research · 23 · $839.2B
- Medical - Devices · 27 · $712.3B
- Medical - Healthcare Plans · 8 · $691.4B
- Medical - Instruments & Supplies · 19 · $377.6B
- Medical - Distribution · 4 · $228.9B
- Medical - Care Facilities · 20 · $219.8B
- Medical - Healthcare Information Services · 8 · $57.4B
- Medical - Specialties · 2 · $51.4B
- Medical - Pharmaceuticals · 5 · $48.5B
Frequently Asked Questions
How many publicly-traded companies are in the Drug Manufacturers - Specialty & Generic industry?
The Drug Manufacturers - Specialty & Generic industry has 14 publicly-listed companies in the US and Canadian markets tracked by Kaplio, with a combined market capitalization of $242.3B.
What is the median P/E ratio of Drug Manufacturers - Specialty & Generic stocks?
The Drug Manufacturers - Specialty & Generic companies above $2 billion with consistent data trade at a median P/E of 30.4. For comparison, the median of the Healthcare sector is 26.6.
What are the largest companies in the Drug Manufacturers - Specialty & Generic industry?
By market capitalization, the largest Drug Manufacturers - Specialty & Generic companies tracked by Kaplio are Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Haleon plc. The full ranking of the top 25 companies by market cap is available above.
Which Drug Manufacturers - Specialty & Generic stocks have the highest dividend yield?
Top dividend payers in Drug Manufacturers - Specialty & Generic include Takeda Pharmaceutical Company Limited, Zoetis Inc., Viatris Inc., with an industry-average dividend yield of 0.9%.
How profitable are Drug Manufacturers - Specialty & Generic companies?
Companies in the Drug Manufacturers - Specialty & Generic industry average a net profit margin of 6.3% and a return on equity (ROE) of 9.4%, based on 14 companies tracked. Average debt-to-equity ratio is 0.86.